Sandu Pharmaceuticals Ltd vs Titan Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Sandu Pharmaceuticals Ltd is ₹ 41.9 as of 06 May 16:01 . The P/E Ratio of Sandu Pharmaceuticals Ltd changed from 33.3 on March 2023 to 0 on March 2022 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Titan Biotech Ltd changed from 6.6 on March 2023 to 10 on March 2022 . This represents a CAGR of 8.67% over 5 years The Market Cap of Sandu Pharmaceuticals Ltd changed from ₹ 50.43 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Titan Biotech Ltd changed from ₹ 162.67 crore on March 2023 to ₹ 216.55 crore on March 2022 . This represents a CAGR of 5.89% over 5 years The revenue of Sandu Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Titan Biotech Ltd for the Dec '25 is ₹ 57.76 crore as compare to the Sep '25 revenue of ₹ 55.68 crore. This represent the growth of 3.74% The ebitda of Sandu Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Titan Biotech Ltd for the Dec '25 is ₹ 12.09 crore as compare to the Sep '25 ebitda of ₹ 10.65 crore. This represent the growth of 13.52% The net profit of Sandu Pharmaceuticals Ltd changed from ₹ 0.17 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The net profit of Titan Biotech Ltd changed from ₹ 5.7 crore to ₹ 7.87 crore over 7 quarters. This represents a CAGR of 20.24% The Dividend Payout of Sandu Pharmaceuticals Ltd changed from 36.33 % on March 2021 to 49.86 % on March 2025 . This represents a CAGR of 6.54% over 5 yearsThe Dividend Payout of Titan Biotech Ltd changed from 4.31 % on March 2021 to 9.04 % on March 2025 . This represents a CAGR of 15.97% over 5 years .

About Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals Limited (SPL) was established in 1987.
The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name 'SANDU' and is having a plant unit in Goa. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations.
This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards.
Ayurvedic products have a very good market in India and abroad due to their minimal side effects. The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97.

About Titan Biotech Ltd

Titan Biotech Limited, the New Delhi based company is into manufacture of Biological Peptones, Extracts and Dehydrated Culture media which are very conducive for the growth of micro organisms.
They are primarily used in the development and growth of micro organisms in clinical diagnosis production of vaccines antibiotics antisera etc, Checking the sensitivity of antibiotics in pharmaceutical industry, checking the bacterial contamination in food & water, tissue culture laboratories and in the departments of microbiology & botony in medical colleges/universities. The company uses Meat, Bile, Pancreatic, Liver, Blood, Brain, Heart and other parts of animals sourced from slaughter house and other vegetable products like soya, casein etc. converting them into free flowing powder to produce Peptones, Extracts and Hydrolysates which are further used in manufacturing of Dehydrated Culture Media and as raw material in pharma health products and other industries.

FAQs for the comparison of Sandu Pharmaceuticals Ltd and Titan Biotech Ltd

Which company has a larger market capitalization, Sandu Pharmaceuticals Ltd or Titan Biotech Ltd?

Market cap of Sandu Pharmaceuticals Ltd is 40 Cr while Market cap of Titan Biotech Ltd is 2,002 Cr

What are the key factors driving the stock performance of Sandu Pharmaceuticals Ltd and Titan Biotech Ltd?

The stock performance of Sandu Pharmaceuticals Ltd and Titan Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sandu Pharmaceuticals Ltd and Titan Biotech Ltd?

As of May 6, 2026, the Sandu Pharmaceuticals Ltd stock price is INR ₹42.11. On the other hand, Titan Biotech Ltd stock price is INR ₹484.7.

How do dividend payouts of Sandu Pharmaceuticals Ltd and Titan Biotech Ltd compare?

To compare the dividend payouts of Sandu Pharmaceuticals Ltd and Titan Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.